Company News
IR Home | SEC Filings | Annual Reports | Company News
Mgmt & Board | Code of Ethics | Webcast
02/08/10 - Lannett CEO Purchases Shares Of Company In Open Market...more
02/08/10 - Lannett Reports Fiscal 2010 Second-Quarter Financial Results...more
02/03/10 - Lannett Company To Report Fiscal 2010 Second-Quarter Financial Results And Host Conference Call On Monday, February 8...more
02/02/10 - Lannett To Submit New Drug Application For Morphine Sulfate Products...more
12/10/09 - Lannett Receives FDA Approvals For Hydromorphone Hydrochloride Tablets USP, 2 MG and 8 MG Strengths...more
11/20/09 - Lannett To Ring New York Stock Exchange Opening Bell...more
11/20/09 - Lannett Reauthorizes Stock Repurchase Program...more
11/09/09 - Lannett Reports Fiscal 2010 First-Quarter Financial Results...more
11/04/09 - Lannett Company To Report Fiscal 2010 First-Quarter Financial Results And Host Conference Call On Monday, November 9, 2009...more
10/14/09 - Lannett Company Names Names Keith Ruck Chief Financial Officer...more
10/02/09 - Lannett Company Files Universal Shelf Registration Statement On Form S-3...more
09/09/09 - Lannett Reports Fiscal 2009 Fourth Quarter, Full-Year Financial Results...more
09/08/09 - Lannett Company To Report Fiscal 2009 Fourth-Quarter, Full-Year Financial Results And Host Conference Call On Wednesday, September 9, 2009...more
09/08/09 - Lannett Company Names Stephen J. Kovary Vice President Operations...more
07/27/09 - Lannett Company Announces Positive FDA Inspection Results...more
07/16/09 - Lannett Company Announces William Farber Resumes Role As Chairman...more
06/22/09 - Lannett Company To Be Added To Russell 2000 Index...more
06/09/09 - Lannett Company Names Terence D. Vollrath Executive Vice President...more
05/12/09 - Lannett Reports Fiscal 2009 Third Quarter Financial Results...more
05/08/09 - Lannett Company Receives FDA Approval For PILOCARPINE HCI Tablets 7.5 MG Strength...more
05/06/09 - Lannett Company To Report Fiscal 2009 Third-Quarter Financial Results And Host Conference Call On Tuesday, May 12, 2009...more
04/02/09 - Lannett Company Announces Chief Financial Officer Resignation...more
04/02/09 - Lannett Company Provides Update On Marketing Digoxin Tablets...more
04/01/09 - Lannett Company Comments On FDA Action...more
02/12/09 - Lannett To Present At Roth 21st Annual Orange County Growth Stock Conference...more
02/11/09 - Lannett Company Reports Fiscal 2009 Second Quarter Financial Results...more
02/11/09 - Lannett Company Inc, And Subsidiaries Consolidated Condensed Balanced Sheets...more
02/06/09 - Lannett Company To Report Fiscal 2009 Second-Quarter Financial Results And Host Conference Call On Wednesday, February 11, 2009...more
12/16/08 - Lannett Company Receives FDA Approval For Ursodiol 300 MG Capsules...more
12/16/08 - Lannett Company Receives FDA Approval For Ursodiol 300 MG Capsules...more
12/11/08 - Lannett Company Announces Launch Of Two Products...more
11/13/08 - Lannett Company Reports Strong Fiscal 2009 First-Quarter Financial Results...more
11/11/08 - Lannett Company Report Fiscal 2009 First-Quarter Financial Results And Host Conference Call On Thursday November 13, 2008...more
10/08/08 - Lannett Company Receives Patent Approval For Method Of Manufatcuring Certain Morphine Derivatives...more
10/06/08 - Lannett Company Announces Positive Results Of Facilties Inspection...more
09/29/08 - Lannett Company Reports Fiscal 2008 Fourth Quarter, Full-Year Financial Results...more
09/10/08 - Lannett Company Announces William Farber, Chairman Of The Board, Takes Medical Leave...more
08/15/08 - Lannett Company Announces Immediate Availability Of Bulk Packs...more
08/01/08 - Lannett Company Receives FDA Approvals For Doxycycline Tablets, 75 MG And 150 MG...more
07/28/08 - Lannett Company Granted Import License From DEA...more
07/25/08 - Lannett Company Comments On Litigation With KV Pharmaceuticals...more
06/02/08 - Lannett Company To Launch Amantadine Hydrochloride Soft Gel Capsules, 100 MG...more
05/15/08 - Lannett Reports Fiscal 2008 Third-Quarter Financial Results...more
05/15/08 - Lannett Company, Inc. And Subsidiaries Consolidated Statements Of Operations...more
05/15/08 - Lannett Company Provides Update On Marketing Digoxin Tablets...more
05/09/08 - Lannett Chairman Transfers Five Millions Shares Of Stock...more
04/30/08 - Lannett Company To Remain A Major Marketer Of Digoxin Tablets...more
04/24/08 - Lannett Company Receives Approval For Dipyridamole Tablets USP, 25 MG, 50 MG, And 75 MG...more
03/31/08 - Lannett Company Receives FDA Approval For Rifampin Capsules USP, 150 MG And 300 MG...more
03/28/08 - Lannett Company Receives FDA Approval For Bethanechol Chloride Tablets USP, 5 MG, 10 MG, 25 MG, And 50 MG...more
02/13/08 - Lannett Company To Present At Roth 20th Annual Growth Stock Conference...more
02/11/08 - Lannett Company Encouraged By Levothyroxine Development In Florida...more
02/08/08 - Lannett Company Reports Fiscal 2008 Second Quarter Financial Results...more
12/12/07 - Lannett Receives FDA Approval For Phentermine...more
11/12/07 - Lannett Company Reports Fiscal 2008 First Quarter Financial Results...more
11/12/07 - Lannett Company, Inc. And Subsidiaries Consolidated Condensed Balance Sheets...more
11/12/07 - Lannett Company, Inc. And Subsidiaries Consolidated Statements Of Operations...more
10/10/07 - Lannett Company Comments On Recent FDA Announcement For Levothyroxine Sodium...more
10/10/07 - Lannett Company Files Form 10-K For Year Ended June 30, 2007; Final Audited Report In Line With Preliminary Financial Results Previously Announced...more
07/12/07 - Lannett Company Receives Approval To Market Baclofen 10 MG Tablets...more
05/30/07 - Lannett Company To Present AT FTN Midwest HealthCare Conference ...more
05/08/07 - Lannett Company, Inc. And Subsidiaries Consolidated Statements Of Operations...more
05/08/07 - Lannett Company, Inc. And Subsidiaries Consolidated Condense Balanced Sheets...more
05/08/07 - Lannett Company Reports Fiscal 2007 Third Quarter Financial Results...more
05/01/07 - Lannett Company UBS Conference Release...more
04/23/07 - Lannett Company Receives Approval For Danazol...more
04/12/07 - Lannett Company Bulk Raw Materials Acquisition...more
02/08/07 - Lannett Company Reports Fiscal 2007 Second Quarter Financial Results...more
01/11/07 - Lannett Company to Commence Marketing Meloxicam for Arthritis...more
01/09/07 - Lannett Company Signs Supply Agreement with Banner Pharmacaps...more
01/03/07 - Lannett Company Signs Research Agreement with Pharmaseed Bioservices...more